Malaysia Infectious Disease Drugs Market Analysis

Malaysia Infectious Disease Drugs Market Analysis


$ 3999

Malaysia Infectious Disease Drugs Market valued at $0.19 Bn in 2023, projected to reach $0.26 Bn by 2030 with a 4.47% CAGR. Factors such as the aging population, economic development, and rising prevalence of infectious diseases drive the industry. The market is dominated by key players like Pharmaniaga Berhad, Kotra Pharma, Duopharma Biotech Berhad, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.

ID: IN10MYPH012 CATEGORY: Pharmaceuticals GEOGRAPHY: Malaysia AUTHOR: Aneri Parekh

Buy Now

Malaysia Infectious Disease Drugs Market Executive Summary

Malaysia Infectious Disease Drugs Market valued at $0.19 Bn in 2023, projected to reach $0.26 Bn by 2030 with a 4.47% CAGR.

In the Malaysian healthcare system, drugs used to treat illnesses brought on by bacteria, viruses, fungi, or parasites are the main focus of the infectious disease drugs market in Malaysia. This market includes a broad spectrum of medications, such as antifungals, antivirals, antibiotics, and antiparasitics. The market is impacted by several factors, including the frequency of infectious diseases, government healthcare policies, regulatory frameworks, and technological and medication development breakthroughs.

The growing prevalence of infectious diseases and the increased emphasis on the development of healthcare infrastructure in Malaysia have resulted in a robust expansion of the infectious disease drug market. Antiviral, antibiotic, and antifungal medicine demand is surging in the market due to factors such as population expansion, urbanization, and changing lifestyles. Major companies are spending money on R&D to launch novel treatments and increase their market share in the area.

In 2023, the global infectious disease drugs market was estimated at $118.75 Bn. Both, an increase in diagnoses and government-led public education initiatives on the management and prevention of infectious diseases, are responsible for this rise. The increasing level of generic competition is indicative of a changing market situation. Long-term growth, especially in emerging nations, requires lowering financial obstacles and expanding access to therapy. This will lead to increased industrial research and development.

Along with Duopharma Biotech and Kotra Pharma, Pharmaniaga Berhad is a significant player in the Malaysian infectious illness drugs market. The company provides antivirals, antibacterials, antifungals, and antiparasitics, among other medications for infectious diseases. The company's primary goal is to produce generic medications that are both high-quality and reasonably priced so that a larger population can use them.

Malaysia infectious disease drugs market

Market Dynamics

Market Growth Drivers:

Growing Prevalence of Infectious Diseases: With the population increase and lifestyle change, there is a rise in the prevalence of infectious diseases including HIV/ AIDS, dengue fever, and tuberculosis. This leads to an increase in demand for medications to treat and prevent these illnesses.

Economic Development: As Malaysia's economy expands and disposable income rises, people are more willing and able to seek healthcare services, including treatment for infectious diseases. The market for infectious illness medications expands as a result of the rising demand for healthcare services.

Aging Population: As Malaysia's population ages, the prevalence of infectious diseases may rise among older persons, who are more vulnerable to some infections due to age-related reductions in immune function. As healthcare professionals try to fulfill the demands of this population segment, this demographic shift helps to drive the market for infectious disease medications.

Market Restraints:

Regulatory Obstacles: Malaysian medicine approval and regulation procedures can be complex and time-consuming. New medications for infectious diseases may take longer to reach the market as a result of delays in regulatory clearance, which may limit patient treatment options.

Competition from Generic Drugs: Pharmaceutical companies operating in Malaysia may face difficulties due to the availability of generic substitutes for branded infectious disease medications.

Economic Factors: People may be prevented from seeking and affording treatment for infectious diseases by economic obstacles such as unemployment, poverty, and restricted access to healthcare coverage.

Healthcare Policies and Regulatory Landscape

According to the Control of Drugs and Cosmetics Regulations of 1984, the Drug Control Authority (DCA) is the executive agency in charge of managing the registration procedure for innovative medicines and biologics in Malaysia. It is necessary to apply online through the QUEST3 system. With QUEST online membership registration, users can securely complete online tasks for product registration applications. DCA requires high-quality data and strict protocol adherence to comply with international requirements for Good Clinical Practice and Good Manufacturing Practice, such as those set forth by the International Council on Harmonization (ICH). This can add complexity and potentially extend timelines. Comprehensive assessments of the safety and effectiveness of medications across diverse populations are necessary in Malaysia, given the country's vast ethnic diversity. Additional clinical studies or data analysis might be necessary for this, which would complicate matters and increase costs.

Competitive Landscape

Key Players:

  • Pharmaniaga Berhad
  • Kotra Pharma
  • Duopharma Biotech Berhad
  • AbbVie Inc.
  • Gilead Sciences
  • Merck & Co.
  • F. Hoffman-La Roche Ltd.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Janssen Pharmaceuticals
  • Novartis AG

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Infectious Disease Drug Market Segmentation

By Disease

  • HIV
  • Influenza
  • Hepatitis
  • Tuberculosis
  • Malaria
  • Other

By Treatment

  • Antibacterial
  • Antiviral
  • Antiparasitic
  • Other

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 11 March 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up